Myocardial Ischemia Clinical Trial
Official title:
Quality of Life in Chronic Ischemic Heart Disease With Left Ventricular Dysfunction
This study will examine the health-related quality of life in patients being treated for
chronic heart disease.
Patients 18 years or older with chronic ischemic heart disease and left ventricular
dysfunction enrolled in protocols in the National Heart Lung and Blood Institute's
Cardiology Branch may participate in this study.
Participants will complete five questionnaires at 3 separate times during the study-once
during hospitalization at the NIH Clinical Center and again at home 6 months and 1 year
later. The questionnaires, described below, require a total of about 30 minutes to complete.
1. Demographic Information Sheet -General information such as age, marital status,
employment, education, and history of cardiac medical procedures.
2. General Health Survey -Patient's self-assessment, on a rating scale, of physical and
emotional well being. Questions are related to the ability to perform work and daily
living activities, mood and state of mind, limitations on social activities, energy
level, pain level, general quality of life, etc.
3. Heart Disease Survey - Patient's self-assessment, on a rating scale, of the level of
physical, social, emotional and functional well being related to his or her heart
condition. Questions concern fatigue level, emotional outlook, social well being, etc.
4. Angina Survey - Information on the frequency of chest pain, chest tightness, or angina.
5. Symptom Distress Survey - Patient's ranking of the degree of symptom distress from
chest discomfort, difficulty breathing, heart rate irregularities, wheezing and
coughing.
All information provided in the questionnaires will be kept confidential. Upon request,
patients will be sent a summary of the study results when the study is completed.
A majority of the research in patients with chronic ischemic heart disease and left
ventricular dysfunction deals with increasing patient survival rates and years. Very little
research has focused on patients' perceptions of living with this chronic debilitating
disease. The purpose of this naturalistic, prospective study is to assess the Health Related
Quality of Life (HRQOL), anginal symptoms and symptom distress experienced by patients with
chronic ischemic heart disease and left ventricular dysfunction. The relationship between
underlying cardiac condition, anginal symptoms, symptom distress and HRQOL will be examined.
The trend in HRQOL across time versus treatment group will be evaluated. The question, does
HRQOL, anginal frequency and symptom distress at baseline predict mortality and cardiac
related hospitalization during the year following assessment will also be addressed.
Patients who are enrolled in protocols in the Cardiology Branch of the National Heart Lung
and Blood Institute (NHLBI) and diagnosed with chronic ischemic heart disease and left
ventricular dysfunction will be asked to participate in this HRQOL study. Patients will
complete measures of HRQOL (Medical Outcomes Short Form 36 Survey; Minnesota Living with
Heart Failure Questionnaire) and symptom measures (anginal frequency subscale of the Seattle
Angina Questionnaire; cardiopulmonary subscale of the Heart Transplant Symptom Checklist).
Underlying cardiac condition will be assessed using exercise thallium imaging parameters
(METS and perfusion defects) and positron emission tomography (PET) imaging parameter
(viability). A sample size of 90 subjects is desired for this study. Data will be analyzed
using multivariate statistics. It is expected that this study will provide new information
regarding how patients with ischemic heart disease and left ventricular function feel their
chronic illness and its corresponding treatment(s) affects their HRQOL.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
| Completed |
NCT04153006 -
Comparison of Fingerstick Versus Venous Sample for Troponin I.
|
||
| Completed |
NCT01205776 -
EXCEL Clinical Trial
|
N/A | |
| Active, not recruiting |
NCT04555174 -
BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
|
||
| Recruiting |
NCT04582877 -
Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial
|
N/A | |
| Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
| Recruiting |
NCT03265535 -
Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging
|
||
| Not yet recruiting |
NCT04522583 -
Increased CRP Concentrations in Patients Admitted to the Emergency Department With Troponin Elevation Aids to Rule Out Coronary Ischemia
|
||
| Completed |
NCT02510547 -
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
|
Phase 4 | |
| Terminated |
NCT02407626 -
Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery
|
N/A | |
| Completed |
NCT02554006 -
Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings
|
N/A | |
| Active, not recruiting |
NCT02189499 -
Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent
|
Phase 2 | |
| Completed |
NCT02197065 -
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
|
Phase 2 | |
| Completed |
NCT02264717 -
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT01681381 -
Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization
|
N/A | |
| Terminated |
NCT01892917 -
BIOFLOW-III Hungary Satellite Registry
|
N/A | |
| Completed |
NCT01679886 -
Comparison of Rubidium PET and SPECT With CZT Crystals for Detection of Myocardial Ischemia in Overweighed Patients and Women
|
N/A | |
| Completed |
NCT01655043 -
Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
|
Phase 2 | |
| Completed |
NCT02707445 -
Genotyping Influences Outcome of Coronary Artery Stenting
|
N/A |